Buy Stocks Easy | About Us

September 24, 2021

OVID

Buy Ovid Therapeutics Inc. Stock (symbol: OVID) Easy Online

Company Name: Ovid Therapeutics Inc.

Symbol: OVID

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2017

OVID Current Share Price

Today's OVID ( Ovid Therapeutics Inc. ) opening price: $4.3700

Yesterday's OVID ( Ovid Therapeutics Inc. ) closing price: $4.3700

Ovid Therapeutics Inc. Stock ( symbol: OVID ) Price Chart since IPO (2017):

12 Months Ovid Therapeutics Inc. Stock ( symbol: OVID ) Price Chart

Popular Questions about Ovid Therapeutics Inc. Public Stock ( OVID )

A: Ovid Therapeutics Inc. stock symbol (also called stock or share ticker) is OVID

A: Ovid Therapeutics Inc. IPO (Initial Public Offering) took place on 2017

A: Ovid Therapeutics Inc.'s stock (OVID symbol) price at ther IPO (initial Public Offering) was $4.3700

Q: Is OVID stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Ovid Therapeutics Inc. stock (symbol: OVID) at the beginning of 2019, at the opening share price of $2.8300, with a minimum of $200, by now your shares would be worth $14334 and your profit would be $14134 - SHOW ONLY IF PROFIT.

Buy Ovid Therapeutics Inc. Stock Easy Online

Ovid Therapeutics Inc. Stock Ticker Price Chart since IPO:

Ovid Therapeutics Inc. Stock Price Yesterday

Ovid Therapeutics Inc. Stock Price – Last Week

Ovid Therapeutics Inc. Stock Price – Last Month

Ovid Therapeutics Inc. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.globenewswire.com/news-release/2019/11/18/1948976/0/en/Ovid-Therapeutics-Appoints-Jason-Tardio-as-Chief-Commercial-Officer.html

Ovid Therapeutics Appoints Jason Tardio as Chief Commercial Officer

Seasoned CNS and Rare Disease Commercial Executive Further Strength...

https://investorplace.com/2019/11/10-cheap-stocks-to-buy-under-10/

10 Cheap Stocks to Buy Under $10

These stocks come from a variety of industries, but all have positi...

https://investorplace.com/2019/10/5-strong-buy-stocks-under-5-with-massive-upside-potential/

5 Strong Buy Stocks Under $5 With Massive Upside Potential

Snapping up strong buy stocks with great long-term growth prospects...

http://www.zacks.com/stock/news/567061/will-ovid-therapeutics-continue-to-surge-higher

Will Ovid Therapeutics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor O...

http://www.globenewswire.com/news-release/2019/10/04/1925295/0/en/Ovid-Therapeutics-Announces-Pricing-of-32-5-Million-of-Securities-in-Concurrent-Public-Offerings-of-Common-Stock-and-Preferred-Stock.html

Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock

NEW YORK, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc...

http://www.globenewswire.com/news-release/2019/10/03/1925031/0/en/Ovid-Therapeutics-Announces-Proposed-Concurrent-Public-Offerings-of-Common-Stock-and-Preferred-Stock.html

Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc...

http://www.globenewswire.com/news-release/2019/09/23/1919034/0/en/Ovid-Therapeutics-Announces-Positive-Initial-Data-from-Ongoing-ENDYMION-Open-Label-Extension-Trial-of-Soticlestat-in-People-with-Rare-Epilepsies.html

Ovid Therapeutics Announces Positive Initial Data from Ongoing ENDYMION Open-Label Extension Trial of Soticlestat in People with Rare Epilepsies

Sustained and Progressively-Improving Median Seizure Frequency Redu...

http://www.globenewswire.com/news-release/2019/09/09/1912673/0/en/Ovid-Therapeutics-to-Present-at-the-H-C-Wainwright-21st-Annual-Global-Investment-Conference.html

Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics In...

http://www.globenewswire.com/news-release/2019/09/03/1909944/0/en/Ovid-Therapeutics-Announces-Participation-in-Two-Upcoming-Investor-Conferences.html

Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences

NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics In...

https://247wallst.com/healthcare-business/2019/07/02/tuesdays-biggest-biotech-movers/

Tuesday’s Biggest Biotech Movers (July 2)

Despite this truncated trading week, Tuesday was a breakout day for...

All right reserved Buy Stocks Easy , 2019.